Results 291 to 300 of about 437,642 (362)

Cell cycle-related biomarker lineage promotes the malignant progression of recurrent IDH wild-type glioma. [PDF]

Discov Oncol
Xu J, Zhang Y, Fan W, Ma W, Bao Z, Wang H.   +5 more
europepmc   +1 more source

Matrix Type Influences the Levels of Soluble Immune Checkpoints

Journal of Clinical Laboratory Analysis, EarlyView.
This study aimed to assess whether the quantification of soluble immune checkpoints (sICs) is comparable between serum and EDTA‐plasma samples. We quantified 17 sICs by a multiplex bead‐based assay in paired serum and plasma‐EDTA samples collected from a cohort of 38 healthy subjects.
Veronica Buia, Martina Bonacini, Cecilia Catellani, Alessandro Rossi, Francesco Muratore, Carlo Salvarani, Alessandro Zerbini, Stefania Croci   +7 more
wiley   +1 more source

LncRNA ZFHX4-AS1 initiates an oncogenic axis involving a ZFHX4/SOX2 positive feedback loop to accelerate glioma progression. [PDF]

Front Oncol
Yan H, Wang X, Zhao Z.
europepmc   +1 more source

Identification of exosome miRNAs regulated by SPHK2 in human glioma cells. [PDF]

Front Oncol
Liu J, Zhao H, Liu X, Guan X, Guo Q, Xu Y, Qiu J.   +6 more
europepmc   +1 more source

Glioma tumor microenvironment and immunotherapy: past, present, and future. [PDF]

Biomark Res
Cvitković J, Tan WL, Jiang T, Zhao Z.
europepmc   +1 more source

Comprehensive analysis of palmitoylation-related proteins for prognostic risk evaluation and tumor immune microenvironment assessment in glioma. [PDF]

Front Immunol
Xue J, Lin L, Liu C, Yin Q, Wang T, Lai R, Chen L, Yin Y, Wang M, Zhou J.   +9 more
europepmc   +1 more source

Unveiling the prognostic and immunological role of IFI44 in glioma. [PDF]

Ann Med
Jin D, Mao L, Wu Y, Tang T, Yan E, Song Z.   +5 more
europepmc   +1 more source

Claudins proteins in brain tumors: expression patterns and therapeutic target. [PDF]

Biochem Med (Zagreb)
Romanowicz A, Łukaszewicz-Zając M, Mroczko B.   +2 more
europepmc   +1 more source